Crystalline forms of vilazodone hydrochloride and vilazodone free base

a technology of vilazodone and hydrochloride, which is applied in the field of crystalline forms of vilazodone hydrochloride and vilazodone free base, can solve the problems of no “standard", the inability to predict the number of polymorphic forms of a given compound, and the inability to achieve the effect of increasing the number of polymorphic forms

Inactive Publication Date: 2015-05-07
DR REDDYS LAB LTD
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0114]The fifty eighth aspect of the present application relates to a process for preparing 3-(4-chlorobutyl)-1H-indole-5-carbonitrile by reducing 3-(4-chlorobutanoyl)-1H-indole-5-carbonitrile in presence of sodium borohydride and boron trifluoride etherate.
[0115]The fifty ninth aspect of the present application relates to pharmaceutical compositions compri

Problems solved by technology

The existence and possible numbers of polymorphic forms for a given compound cannot be predicted, a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystalline forms of vilazodone hydrochloride and vilazodone free base
  • Crystalline forms of vilazodone hydrochloride and vilazodone free base
  • Crystalline forms of vilazodone hydrochloride and vilazodone free base

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Crystalline Form B of Vilazodone Hydrochloride

example 1a

[0383]Vilazodone free base (118 g) and methanol (2360 mL) were charged into a round bottom flask at ambient temperature. The resulting mixture was cooled to 4° C. and 10% w / w methanolic hydrochloric acid solution (236 mL) was slowly added, stirred the resulting solution at 0-5° C. for 30 minutes. The solid was collected by filtration and dried at 45-50° C. for 3.5 hours to afford the title compound.

[0384]Yield: 107.6 g;

[0385]Water Content: 8.46% w / w as measured by Karl Fischer method.

[0386]The PXRD pattern of crystalline Form B of vilazodone hydrochloride obtained is in accordance with FIG. 1.

example 1b

[0387]Vilazodone free base (1.5 g) and methanol (30 mL) were charged into a round bottom flask at −10° C. 10% w / w Methanolic hydrochloric acid solution (3 mL) was slowly added to the resulting mixture at −10° C. and further stirred for 30 minutes. The solid was collected by filtration and dried at 45-50° C. for 30 minutes to afford the title compound.

[0388]Yield: 1.4 g

[0389]Water Content: 8.46% w / w as measured by Karl Fischer method.

[0390]The PXRD pattern of crystalline Form B of vilazodone hydrochloride obtained is in accordance with FIG. 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Angleaaaaaaaaaa
Angleaaaaaaaaaa
Angleaaaaaaaaaa
Login to view more

Abstract

Provided are crystalline and amorphous vilazodone hydrochloride. Further provided are amorphous solid dispersions of vilazodone hydrochloride with pharmaceutically acceptable carries. Also provided is a process for the preparation of form I of vilazodone free base.

Description

INTRODUCTION[0001]One aspect of the present application relates to crystalline forms B, C, D, E, F, G and H of Vilazodone hydrochloride. Another aspect of the present application relates to amorphous vilazodone hydrochloride and a process for preparation thereof. Yet another aspect of the present application relates to amorphous solid dispersions of vilazodone hydrochloride. Still another aspect of the present application relates to a process for the preparation of vilazodone free base. Another aspect of the present application relates to crystalline form I of vilazodone free base.[0002]Vilazodone hydrochloride is selective serotonin reuptake inhibitor, which also acts as partial agonist at serotonergic 5-HT1A receptors. It is mainly used for the treatment of major depressive disorder (MDD) and marketed as Viibryd™ in tablet dosage forms. The vilazodone hydrochloride is chemically known as 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D405/12
CPCC07D405/12A61P25/24C07D405/14C07B2200/13
Inventor IQBAL, JAVEDORUGANTI, SRINIVASRAPOLU, RAJESH KUMARPEDDY, VISHWESHWARBOGE, RAJESHAMPATHIVADA, DEEPIKAVELAGA, DHARMA JAGANNADHA RAOYARRAGUNTLA, SESHA REDDYBADDAM, SUDHAKAR REDDYNAREDLA, ANITHADONIPARTHI, KIRAN KUMARNADGOUD, RAMESH KUMARPAGADALA, NARASIMHA RAOUNNIARAN, SYAM KUMARRAMAKRISHNAN, SRIVIDYA
Owner DR REDDYS LAB LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap